100 related articles for article (PubMed ID: 23313585)
1. How well does self-reported adherence fare compared to therapeutic drug monitoring in HAART?
Bulgiba A; Mohammed UY; Chik Z; Lee C; Peramalah D
Prev Med; 2013; 57 Suppl():S34-6. PubMed ID: 23313585
[TBL] [Abstract][Full Text] [Related]
2. Predictors of short-term success of antiretroviral therapy in HIV infection.
Oette M; Kroidl A; Göbels K; Stabbert A; Menge M; Sagir A; Kuschak D; O'hanley T; Bode JG; Häussinger D
J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458
[TBL] [Abstract][Full Text] [Related]
3. Nevirapine concentrations in saliva measured by thin layer chromatography and self-reported adherence in patients on antiretroviral therapy at Kilimanjaro Christian Medical Centre, Tanzania.
George L; Muro EP; Ndaro A; Dolmans W; Burger DM; Kisanga ER
Ther Drug Monit; 2014 Jun; 36(3):366-70. PubMed ID: 24305625
[TBL] [Abstract][Full Text] [Related]
4. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
[TBL] [Abstract][Full Text] [Related]
5. Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy.
Gianotti N; Galli L; Bocchiola B; Cahua T; Panzini P; Zandonà D; Salpietro S; Maillard M; Danise A; Pazzi A; Lazzarin A; Castagna A
HIV Med; 2013 Mar; 14(3):153-60. PubMed ID: 22994659
[TBL] [Abstract][Full Text] [Related]
6. Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection.
Fabbiani M; Di Giambenedetto S; Cingolani A; Fanti I; Colafigli M; Tamburrini E; Cauda R; Navarra P; De Luca A; Murri R
Infect Dis (Lond); 2016; 48(1):48-55. PubMed ID: 26329383
[TBL] [Abstract][Full Text] [Related]
7. Adherence to HIV therapeutic drug monitoring guidelines in The Netherlands.
van Luin M; Wit FW; Smit C; Rigter IM; Franssen EJ; Richter C; Kroon F; de Wolf F; Burger DM
Ther Drug Monit; 2011 Feb; 33(1):32-9. PubMed ID: 21192311
[TBL] [Abstract][Full Text] [Related]
8. Single-measurement therapeutic drug monitoring of the HIV/AIDS drugs abacavir, zidovudine, lamivudine, efavirenz, nevirapine, lopinavir and nelfinavir.
Donnerer J; Haas BJ; Kessler HH
Pharmacology; 2008; 82(4):287-92. PubMed ID: 18931536
[TBL] [Abstract][Full Text] [Related]
9. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
10. Assessing adherence in Thai patients taking combination antiretroviral therapy.
Kerr SJ; Avihingsanon A; Putcharoen O; Chetchotisakd P; Layton M; Ubolyam S; Ruxrungtham K; Cooper DA; Phanuphak P; Duncombe C
Int J STD AIDS; 2012 Mar; 23(3):160-5. PubMed ID: 22581867
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Antiretroviral Therapeutic Drug Monitoring: A Five and a Half Year Experience from a South African Tertiary Hospital.
Engelbrecht AE; Wiesner L; Norman J; Rabie H; Decloedt EH
J Trop Pediatr; 2020 Aug; 66(4):385-394. PubMed ID: 31754710
[TBL] [Abstract][Full Text] [Related]
12. The advantages of therapeutic drug monitoring in patients receiving antiretroviral treatment and experiencing medication-related problems.
Schoenenberger JA; Aragones AM; Cano SM; Puig T; Castello A; Gomez-Arbones X; Porcel JM
Ther Drug Monit; 2013 Feb; 35(1):71-7. PubMed ID: 23188184
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with adherence to highly active antiretroviral therapy among children in two referral hospitals, northwest Ethiopia.
Azmeraw D; Wasie B
Ethiop Med J; 2012 Apr; 50(2):115-24. PubMed ID: 22924280
[TBL] [Abstract][Full Text] [Related]
14. Adherence to ARV medication in Romanian young adults: self-reported behaviour and psychological barriers.
Dima AL; Schweitzer AM; Diaconiţ R; Remor E; Wanless RS
Psychol Health Med; 2013; 18(3):343-54. PubMed ID: 22985131
[TBL] [Abstract][Full Text] [Related]
15. Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz.
Cooper V; Moyle GJ; Fisher M; Reilly G; Ewan J; Liu HC; Horne R;
AIDS Care; 2011 Jun; 23(6):705-13. PubMed ID: 21476152
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of pharmacy dispensing records in the evaluation of adherence to antiretroviral therapy in Brazilian children and adolescents.
Ernesto AS; Lemos RM; Huehara MI; Morcillo AM; Dos Santos Vilela MM; Silva MT
Braz J Infect Dis; 2012; 16(4):315-20. PubMed ID: 22846117
[TBL] [Abstract][Full Text] [Related]
18. Measuring medication adherence: are missed doses reported more accurately then perfect adherence?
Wagner GJ; Rabkin JG
AIDS Care; 2000 Aug; 12(4):405-8. PubMed ID: 11091773
[TBL] [Abstract][Full Text] [Related]
19. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
[TBL] [Abstract][Full Text] [Related]
20. Determination of abacavir, amprenavir, didanosine, efavirenz, nevirapine, and stavudine concentration in human plasma by MALDI-TOF/TOF.
Notari S; Mancone C; Alonzi T; Tripodi M; Narciso P; Ascenzi P
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Mar; 863(2):249-57. PubMed ID: 18258495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
